Myszkowski Kenneth Allen
Insider CIK 1486672 · ARWR Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-01-07 | 2025-01-07 | 8,000 | $19.70 | $157.6K | 465,433 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-01-07 | 2025-01-07 | 10,000 | $19.69 | $196.9K | 455,433 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-01-06 | 2025-01-07 | 9,402 | $20.10 | $189.0K | 473,433 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-01-06 | 2025-01-07 | 17,765 | $19.68 | $349.6K | 482,835 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2025-01-04 | 2025-01-07 | 100,000 | — | $0 | 500,600 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2024-03-06 | 2024-03-08 | 40,000 | $35.19 | $1.41M | 400,600 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2024-01-05 | 2024-01-08 | 1,400 | $34.04 | $47.7K | 455,304 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2024-01-05 | 2024-01-08 | 8,904 | $35.65 | $317.4K | 440,600 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2024-01-05 | 2024-01-08 | 5,800 | $34.97 | $202.8K | 449,504 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2024-01-04 | 2024-01-08 | 75,000 | — | $0 | 456,704 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2023-06-27 | 2023-06-29 | 15,000 | $36.20 | $543.0K | 381,704 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2023-01-04 | 2023-01-05 | 60,000 | — | $0 | 396,704 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2022-12-29 | 2022-12-30 | 30,625 | $40.00 | $1.23M | 336,704 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2022-01-05 | 2022-01-06 | 16,528 | $62.00 | $1.02M | 471,569 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2022-01-05 | 2022-01-06 | 3,778 | $63.17 | $238.7K | 467,791 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2022-01-05 | 2022-01-06 | 3,786 | $63.95 | $242.1K | 464,005 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2022-01-05 | 2022-01-06 | 15,908 | $60.50 | $962.4K | 488,097 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2022-01-01 | 2022-01-04 | 60,000 | — | $0 | 504,005 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2021-01-12 | 2021-01-12 | 1,441 | $81.00 | $116.7K | 444,005 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2021-01-11 | 2021-01-12 | 11,597 | $81.02 | $939.6K | 445,446 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2021-01-06 | 2021-01-07 | 25,166 | $72.63 | $1.83M | 457,043 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2021-01-06 | 2021-01-07 | 1,100 | $70.75 | $77.8K | 486,568 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2021-01-06 | 2021-01-07 | 4,359 | $71.77 | $312.8K | 482,209 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2021-01-01 | 2021-01-05 | 60,000 | — | $0 | 487,668 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2020-11-09 | 2020-11-12 | 43,505 | — | $0 | 0 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-11-09 | 2020-11-12 | 25,840 | $69.04 | $1.78M | 445,333 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-11-09 | 2020-11-12 | 17,665 | $69.86 | $1.23M | 427,668 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2020-11-09 | 2020-11-12 | 43,505 | $14.54 | $632.6K | 471,173 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2020-10-20 | 2020-10-22 | 29,166 | — | $0 | 43,505 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-10-20 | 2020-10-22 | 29,166 | $54.04 | $1.58M | 427,668 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2020-10-20 | 2020-10-22 | 29,166 | $6.15 | $179.4K | 456,834 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2020-02-25 | 2020-02-27 | 10,834 | — | $0 | 72,671 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2020-02-25 | 2020-02-27 | 6,495 | — | $0 | 95,621 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2020-02-25 | 2020-02-27 | 12,116 | — | $0 | 83,505 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2020-02-25 | 2020-02-27 | 2,000 | — | $0 | 102,116 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2020-02-25 | 2020-02-27 | 12,000 | — | $0 | 104,116 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2020-02-25 | 2020-02-27 | 2,000 | $5.19 | $10.4K | 398,223 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2020-02-25 | 2020-02-27 | 12,000 | $9.90 | $118.8K | 396,223 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2020-02-25 | 2020-02-27 | 10,834 | $6.15 | $66.6K | 427,668 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2020-02-25 | 2020-02-27 | 12,116 | $7.75 | $93.9K | 416,834 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2020-02-25 | 2020-02-27 | 6,495 | $14.54 | $94.4K | 404,718 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2020-01-21 | 2020-01-23 | 33,351 | — | $0 | 116,116 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-01-21 | 2020-01-23 | 10,680 | $51.11 | $545.9K | 387,673 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-01-21 | 2020-01-23 | 2,800 | $49.98 | $139.9K | 398,353 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-01-21 | 2020-01-23 | 10,554 | $49.07 | $517.9K | 401,153 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-01-21 | 2020-01-23 | 3,450 | $52.13 | $179.8K | 384,223 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-01-21 | 2020-01-23 | 6,397 | $47.07 | $301.1K | 418,139 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2020-01-21 | 2020-01-23 | 33,351 | $5.19 | $173.1K | 424,536 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-01-21 | 2020-01-23 | 6,432 | $47.93 | $308.3K | 411,707 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-01-06 | 2020-01-08 | 11,907 | $60.40 | $719.2K | 391,685 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-01-06 | 2020-01-08 | 500 | $60.95 | $30.5K | 391,185 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-01-06 | 2020-01-08 | 7,593 | $59.60 | $452.5K | 403,592 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2020-01-01 | 2020-01-03 | 85,000 | — | $0 | 411,185 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2019-11-05 | 2019-11-07 | 12,649 | — | $0 | 149,467 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2019-11-05 | 2019-11-07 | 12,649 | $5.19 | $65.6K | 326,185 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2019-11-01 | 2019-11-01 | 37,884 | — | $0 | 162,116 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2019-11-01 | 2019-11-01 | 37,884 | $7.75 | $293.6K | 351,420 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-11-01 | 2019-11-01 | 21,264 | $40.56 | $862.5K | 330,156 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-11-01 | 2019-11-01 | 16,620 | $41.21 | $684.9K | 313,536 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2019-05-31 | 2019-06-03 | 20,000 | — | $0 | 200,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2019-05-31 | 2019-06-03 | 15,000 | — | $0 | 220,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2019-05-31 | 2019-06-03 | 15,000 | $4.60 | $69.0K | 293,536 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2019-05-31 | 2019-06-03 | 20,000 | $5.19 | $103.8K | 313,536 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-05-21 | 2019-05-22 | 27,071 | $22.00 | $595.6K | 278,536 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2019-02-19 | 2019-02-20 | 8,000 | — | $0 | 235,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2019-02-19 | 2019-02-20 | 8,000 | $5.20 | $41.6K | 313,607 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-02-19 | 2019-02-20 | 8,000 | $18.00 | $144.0K | 305,607 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-01-17 | 2019-01-18 | 81,875 | $14.55 | $1.19M | 305,607 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-01-02 | 2019-01-03 | 8,333 | $11.98 | $99.8K | 387,482 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2019-01-01 | 2019-01-03 | 85,000 | — | $0 | 395,815 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2018-09-06 | 2018-09-10 | 25,000 | — | $0 | 263,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2018-09-06 | 2018-09-10 | 20,000 | — | $0 | 243,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2018-09-06 | 2018-09-10 | 20,000 | $4.75 | $95.0K | 355,815 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2018-09-06 | 2018-09-10 | 25,000 | $18.00 | $450.0K | 330,815 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2018-09-06 | 2018-09-10 | 25,000 | $2.62 | $65.5K | 335,815 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2018-09-06 | 2018-09-10 | 20,000 | $21.01 | $420.2K | 310,815 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2018-06-19 | 2018-06-20 | 20,000 | — | $0 | 288,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2018-06-19 | 2018-06-20 | 20,000 | $14.01 | $280.2K | 310,815 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2018-06-19 | 2018-06-20 | 20,000 | $2.01 | $40.2K | 330,815 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2018-05-31 | 2018-06-01 | 12,600 | — | $0 | 308,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2018-05-31 | 2018-06-01 | 12,600 | $11.00 | $138.6K | 310,815 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2018-05-31 | 2018-06-01 | 12,600 | $2.01 | $25.3K | 323,415 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2018-05-30 | 2018-06-01 | 1,400 | — | $0 | 320,600 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2018-05-30 | 2018-06-01 | 1,400 | $11.00 | $15.4K | 310,815 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2018-05-30 | 2018-06-01 | 1,400 | $2.01 | $2.8K | 312,215 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2018-03-27 | 2018-03-27 | 20,000 | — | $0 | 322,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2018-03-27 | 2018-03-27 | 20,000 | $8.00 | $160.0K | 310,815 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2018-03-27 | 2018-03-27 | 20,000 | $2.01 | $40.2K | 330,815 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | F Tax w/h | 2018-03-05 | 2018-03-05 | 8,208 | $6.66 | $54.7K | 310,815 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2018-01-01 | 2018-01-03 | 75,000 | — | $0 | 319,023 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2017-01-01 | 2017-01-04 | 145,000 | — | $0 | 260,689 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2016-08-23 | 2016-08-24 | 6,900 | — | $0 | 342,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2016-08-23 | 2016-08-26 | 6,900 | — | $0 | 342,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2016-08-23 | 2016-08-24 | 6,900 | $8.00 | $55.2K | 115,689 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2016-08-23 | 2016-08-24 | 6,900 | $2.01 | $13.9K | 122,589 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2016-08-23 | 2016-08-26 | 6,900 | $2.01 | $13.9K | 122,589 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2016-08-23 | 2016-08-26 | 6,900 | $8.00 | $55.2K | 115,689 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2016-08-22 | 2016-08-24 | 13,100 | — | $0 | 348,900 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2016-08-22 | 2016-08-26 | 13,100 | — | $0 | 348,900 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2016-08-22 | 2016-08-24 | 13,100 | $8.00 | $104.8K | 115,689 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2016-08-22 | 2016-08-24 | 13,100 | $2.01 | $26.3K | 128,789 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2016-08-22 | 2016-08-26 | 13,100 | $2.01 | $26.3K | 128,789 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2016-08-22 | 2016-08-26 | 13,100 | $8.00 | $104.8K | 115,689 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | F Tax w/h | 2016-03-04 | 2016-03-08 | 6,263 | $4.33 | $27.1K | 115,689 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | F Tax w/h | 2016-02-06 | 2016-02-09 | 13,048 | $3.46 | $45.1K | 121,952 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award deriv | 2016-01-01 | 2016-01-04 | 40,000 | — | $0 | 362,000 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award | 2016-01-01 | 2016-01-04 | 50,000 | — | $0 | 135,000 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | S Sale | 2015-12-30 | 2016-01-04 | 23,347 | $6.13 | $143.1K | 85,000 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | F Tax w/h | 2015-12-30 | 2016-01-04 | 13,153 | $6.13 | $80.6K | 108,347 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award deriv | 2015-03-06 | 2015-03-06 | 50,000 | — | $0 | 322,000 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award | 2015-03-04 | 2015-03-06 | 50,000 | — | $0 | 121,500 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | M Exercise deriv | 2014-08-15 | 2014-08-19 | 25,000 | — | $0 | 272,000 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | M Exercise deriv | 2014-08-15 | 2014-08-19 | 15,000 | — | $0 | 297,000 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | S Sale | 2014-08-15 | 2014-08-19 | 40,000 | $14.02 | $560.8K | 71,500 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | M Exercise | 2014-08-15 | 2014-08-19 | 25,000 | $7.00 | $175.0K | 111,500 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | M Exercise | 2014-08-15 | 2014-08-19 | 15,000 | $5.19 | $77.8K | 86,500 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | M Exercise deriv | 2014-02-12 | 2014-02-12 | 16,000 | — | $0 | 312,000 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | M Exercise | 2014-02-12 | 2014-02-12 | 16,000 | $2.01 | $32.2K | 87,500 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | S Sale | 2014-02-12 | 2014-02-12 | 16,000 | $18.77 | $300.3K | 71,500 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award deriv | 2014-02-06 | 2014-02-10 | 50,000 | — | $0 | 328,000 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award | 2014-02-06 | 2014-02-10 | 70,000 | — | $0 | 71,500 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award deriv | 2013-09-21 | 2013-09-24 | 20,000 | — | $0 | 278,000 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award deriv | 2013-05-06 | 2013-05-08 | 90,000 | — | $0 | 258,000 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award deriv | 2012-09-28 | 2012-10-02 | 25,000 | — | $0 | 168,000 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award deriv | 2012-02-16 | 2012-02-21 | 83,000 | — | $0 | 143,000 | SEC↗ |